LMN-301

N/A

Report date: 2024/11/07 16:30:21

Base Information

Drug NameLMN-301
Drug Alias NameLMN301
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLumen Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesLumen Bioscience Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A